2023 - Research.com Medicine in Belgium Leader Award
His scientific interests lie mostly in Internal medicine, Myocardial infarction, Cardiology, Surgery and Acute coronary syndrome. Frans Van de Werf combines subjects such as Stroke and Heart failure with his study of Myocardial infarction. His Stroke study combines topics from a wide range of disciplines, such as Anesthesia, Streptokinase, Aspirin and Clinical endpoint.
As part of the same scientific family, Frans Van de Werf usually focuses on Cardiology, concentrating on Fibrinolytic agent and intersecting with Tenecteplase and Survival rate. The study incorporates disciplines such as Placebo, Tissue plasminogen activator and Risk factor in addition to Surgery. Frans Van de Werf interconnects Mortality rate, Emergency medicine, Clopidogrel, Severity of illness and Angina in the investigation of issues within Acute coronary syndrome.
Frans Van de Werf mainly focuses on Internal medicine, Cardiology, Myocardial infarction, Surgery and Acute coronary syndrome. His work on Percutaneous coronary intervention, ST segment, Thrombolysis and Conventional PCI is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science. Many of his studies involve connections with topics such as Hazard ratio and Cardiology.
His Myocardial infarction study combines topics in areas such as Stroke, Fibrinolytic agent and Randomized controlled trial. His research investigates the connection between Randomized controlled trial and topics such as Clinical trial that intersect with problems in Intensive care medicine. His studies in Acute coronary syndrome integrate themes in fields like Platelet aggregation inhibitor and Clopidogrel.
His primary areas of investigation include Internal medicine, Cardiology, Myocardial infarction, Acute coronary syndrome and Percutaneous coronary intervention. His Stroke, ST segment, Hazard ratio, Vorapaxar and Heart failure study are his primary interests in Internal medicine. His work on TIMI, Ticagrelor and Coronary artery disease as part of general Cardiology study is frequently linked to In patient, therefore connecting diverse disciplines of science.
The Myocardial infarction study combines topics in areas such as Fibrinolysis, Fibrinolytic agent and Surgery. His Acute coronary syndrome research is multidisciplinary, incorporating elements of Platelet aggregation inhibitor, Observational study, Clinical trial, Revascularization and Prospective cohort study. His Percutaneous coronary intervention study combines topics in areas such as Reperfusion therapy, Cardiogenic shock, Stent, Infarction and Electrocardiography.
Internal medicine, Myocardial infarction, Cardiology, Acute coronary syndrome and Percutaneous coronary intervention are his primary areas of study. His research on Internal medicine frequently connects to adjacent areas such as Surgery. Frans Van de Werf combines subjects such as Fibrinolytic agent, Confidence interval and Emergency medicine with his study of Myocardial infarction.
The various areas that Frans Van de Werf examines in his Cardiology study include Clinical endpoint and Randomized controlled trial. His Acute coronary syndrome research incorporates themes from Platelet aggregation inhibitor, Observational study, Framingham Risk Score and Prospective cohort study. The concepts of his Percutaneous coronary intervention study are interwoven with issues in Survival rate, Incidence and Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
Maarten Simoons;Eric Topol;Robert Califf;Frans van de Werf.
The New England Journal of Medicine (1993)
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.
Frans Van de Werf;Jeroen Bax;Amadeo Betriu;Carina Blomstrom-Lundqvist.
European Heart Journal (2008)
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
Marc A. Pfeffer;John J.V. McMurray;Eric J. Velazquez;Jean-Lucien Rouleau.
The New England Journal of Medicine (2003)
Predictors of hospital mortality in the global registry of acute coronary events.
Christopher B. Granger;Robert J. Goldberg;Omar Dabbous;Karen S. Pieper.
JAMA Internal Medicine (2003)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B Green;M. Angelyn Bethel;Paul W Armstrong;John B Buse.
The New England Journal of Medicine (2015)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).
Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet.
European Heart Journal (2018)
Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study
Benjamin F. Voight;Benjamin F. Voight;Benjamin F. Voight;Gina M. Peloso;Gina M. Peloso;Marju Orho-Melander;Ruth Frikke-Schmidt.
web science (2012)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli;Héctor Bueno;Robert A. Byrne;Jean-Philippe Collet.
European Journal of Cardio-Thoracic Surgery (2018)
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.
Frans Van de Werf;Diego Ardissino;Amadeo Betriu;Dennis V. Cokkinos.
European Heart Journal (2003)
A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry
Kim A Eagle;Michael J Lim;Omar H Dabbous;Karen S Pieper.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: